You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

CLINICAL TRIALS PROFILE FOR MOLINDONE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for MOLINDONE HYDROCHLORIDE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00053703 ↗ Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS) Completed National Institute of Mental Health (NIMH) Phase 4 2002-02-01 This study will evaluate the safety and efficacy of risperidone (Risperdal®), olanzapine (Zyprexa®), and molindone (Moban®) for the treatment of children and adolescents with schizophrenia or schizoaffective disorder.
NCT00053703 ↗ Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS) Completed University of North Carolina, Chapel Hill Phase 4 2002-02-01 This study will evaluate the safety and efficacy of risperidone (Risperdal®), olanzapine (Zyprexa®), and molindone (Moban®) for the treatment of children and adolescents with schizophrenia or schizoaffective disorder.
NCT01416064 ↗ Open-Label, Extension Study to 810P202 Completed Supernus Pharmaceuticals, Inc. Phase 2 2011-09-01 Open-label, extension study for subjects that completed 810P202 to examine long term safety and tolerability of repeated dosing of SPN-810M as an adjunctive therapy in children with Impulsive Aggression Comorbid with Attention-Deficit/Hyperactivity Disorder (ADHD).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for MOLINDONE HYDROCHLORIDE

Condition Name

Condition Name for MOLINDONE HYDROCHLORIDE
Intervention Trials
Impulsive Aggression Comorbid With ADHD in Children 1
Schizophrenia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for MOLINDONE HYDROCHLORIDE
Intervention Trials
Aggression 1
Schizophrenia 1
Impulsive Behavior 1
Attention Deficit Disorder with Hyperactivity 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for MOLINDONE HYDROCHLORIDE

Trials by Country

Trials by Country for MOLINDONE HYDROCHLORIDE
Location Trials
United States 19
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for MOLINDONE HYDROCHLORIDE
Location Trials
Washington 2
Ohio 2
Illinois 1
Indiana 1
Kentucky 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for MOLINDONE HYDROCHLORIDE

Clinical Trial Phase

Clinical Trial Phase for MOLINDONE HYDROCHLORIDE
Clinical Trial Phase Trials
Phase 4 1
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for MOLINDONE HYDROCHLORIDE
Clinical Trial Phase Trials
Completed 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for MOLINDONE HYDROCHLORIDE

Sponsor Name

Sponsor Name for MOLINDONE HYDROCHLORIDE
Sponsor Trials
National Institute of Mental Health (NIMH) 1
University of North Carolina, Chapel Hill 1
Supernus Pharmaceuticals, Inc. 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for MOLINDONE HYDROCHLORIDE
Sponsor Trials
NIH 1
Other 1
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.